Clinical Trials Logo

Filter by:
NCT ID: NCT01980199 Terminated - Clinical trials for Visceral Leishmaniasis

Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan

Start date: November 2013
Phase: Phase 2
Study type: Interventional

This study is designed to determine the efficacy of Fexinidazole as an oral treatment in Visceral Leishmanisasis sudanese adults patients. The results of this proof of concept study will allow to make a decision on whether to proceed with clinical development of Fexinidazole for visceral leishmaniasis.

NCT ID: NCT01841541 Completed - Tuberculosis Clinical Trials

The Impact of Involving Informal Health Providers for Tuberculosis Control in Sudan

Triage-Plus
Start date: January 2009
Phase: N/A
Study type: Interventional

Training and engaging of unpaid informal providers (such as tea-sellers, women's groups, youth clubs, small traders and religious groups) from poorer localities in TB disease recognition, referral and community awareness raising will increase the access of TB patients to formal health facilities and decrease their delay in initiating TB treatment.

NCT ID: NCT01805232 Recruiting - Malaria Clinical Trials

Intravenous Artesunate and Malaria

IVAS
Start date: March 2013
Phase: Phase 4
Study type: Interventional

Intravenous artesunate is egual to quinine in the treatment of severe malaria

NCT ID: NCT01766830 Completed - HIV Clinical Trials

Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)

Start date: January 2013
Phase: N/A
Study type: Interventional

Tropical fevers have been a diagnostic challenge from the antiquity. Nowadays, despite the availability of good diagnostic capacities, undifferentiated febrile illnesses continue to be a thorny problem for travel physicians. In developing countries, the scarcity of skilled personnel and adequate laboratory facilities makes the differential diagnosis of fevers even more complex. Health care workers must often rely on syndrome-oriented empirical approaches to treatment and might overestimate or underestimate the likelihood of certain diseases. For instance Neglected Tropical Diseases (NTD) contribute substantially to the burden of persistent (more than 1 week) fevers in the Tropics, causing considerable mortality and major disability. These diseases are however rarely diagnosed at primary health care (PHC) level. The difficulty in establishing the cause of febrile illnesses has resulted in omission or delays in treatment, irrational prescriptions with polytherapy, increasing cost and development of drug resistance. In resource-limited settings, clinical algorithms constitute a valuable aid to health workers, as they facilitate the therapeutic decision in the absence of good laboratory capacities. There is a critical lack of appropriate diagnostic tools to guide treatment of NTDs. While clinical algorithms have been developed for some NTDs, in most cases they remain empirical. Besides, they rarely take into account local prevalence data, do not adequately represent the spectrum of patients and differential diagnosis at the primary care level and often have not been properly validated. The purpose of the study is to develop evidence-based Rapid Diagnostic Test (RDT)-supported diagnostic guidelines for patients with persistent fever (≥ 1 week) in the Democratic Republic of the Congo (DRC), Sudan, Cambodia and Nepal.

NCT ID: NCT01713517 Recruiting - Malaria, Falciparum Clinical Trials

Impact of Insecticide Resistance on Vector Control

Start date: April 2011
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine whether long lasting insecticidal nets and indoor residual insecticide spraying, alone or in combination, are effective for controlling insecticide resistant anopheles mosquitoes for malaria prevention.

NCT ID: NCT01625871 Completed - Vivax Malaria Clinical Trials

Artemether/Lumefantrine and Vivax Malaria

Start date: September 2011
Phase: Phase 3
Study type: Interventional

The cure rate of artemether/lumefantrine in the treatment of vivax malaria.

NCT ID: NCT01558336 Completed - Schistosomiasis Clinical Trials

Schistosoma Haematobium Infections and Praziquantel

Start date: August 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.

NCT ID: NCT01347593 Completed - Caesarean Clinical Trials

Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery

Start date: May 2011
Phase: Phase 4
Study type: Interventional

Ceftizoxime (Cefizox) will reduce post Cesarean delivery febrile morbidity.

NCT ID: NCT01319734 Recruiting - Clinical trials for Type 2 Diabetes Mellitus

Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus

Vit C
Start date: February 2011
Phase: Phase 1
Study type: Interventional

Null hypothesis: No significant effect of vitamin C 500 mg Supplementation on the severity of micro-vascular complications of type 2 Diabetes Mellitus (DM). Alternative hypothesis: There is a significant effect of vitamin C 500mg supplementation on the severity of the micro-vascular complications of type 2DM.

NCT ID: NCT01075945 Unknown status - Malaria Clinical Trials

Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan

Start date: February 2010
Phase: Phase 4
Study type: Interventional

Dihydroartemisinin- Piperaquine is not inferior to artemether-lumefantrine